Producer

Mead Johnson Nutrition (Reckitt)

HQ US · Glenview, Illinoiswebsite ↗

Second-largest US infant formula manufacturer (40% market share via Enfamil); owned by Reckitt Benckiser (UK) since 2017; major WIC contract holder that gained market share during 2022 Abbott shortage

1

Inputs supplied

1

Goods downstream

0

Facilities

0

Stories

What they make

1 input Mead Johnson Nutrition (Reckitt) supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where it shows up

Goods downstream

Essential goods that depend on something Mead Johnson Nutrition (Reckitt) makes, pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map, where this supply-chain role fits within their broader business.

  • Infant Formula (US + Global)

    60%
  • Pediatric + Adult Nutrition

    20%
  • Parent: Reckitt Benckiser (Hygiene + Health)

    20%

Intelligence

What's known

Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.

  • Did you know2023

    Mead Johnson Nutrition (Enfamil) is owned by Reckitt Benckiser — a British consumer goods conglomerate publicly known for Lysol disinfectant and Durex condoms. Reckitt acquired Mead Johnson for $16.6 billion in 2017 to diversify into health nutrition; the premise was that infant formula had consumer goods brand loyalty and recurring demand similar to Reckitt's hygiene brands. The formula market has an unusual regulatory structure: WIC (the federal Women, Infants, and Children nutrition program) awards sole-source contracts to ONE infant formula brand per state. The WIC sole-source winner captures 60-80% of all formula sales in that state (because WIC families buy the covered brand and retailers stock it heavily). During the 2022 Abbott Similac shortage, Reckitt/Mead Johnson's Enfamil held WIC contracts in most states and benefited from Abbott's crisis — demonstrating that the US infant formula market functions as a quasi-monopoly where one shock (Abbott plant closure) immediately creates a second-brand oligopoly with limited consumer choice. The disinfectant company controls what American infants eat in emergency conditions.

    Mead Johnson Nutrition (Reckitt)